img

Global Gadoterate Meglumine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 264 | Industry : Pharma & Healthcare

Publisher : QMR | Format : PDF

Global Gadoterate Meglumine Market Research Report 2024

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
1.8845Gm/5Ml
3.769Gm/10Ml
5.6535Gm/15Ml
Others


Segment by Application


Hospitals
Clinics

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE




By Company


Guerbet Group
GE
Bayer
Sanochemia
T2Pharma
b.e.imaging GmbH
Hengrui Medicine

Table of Content

1 Gadoterate Meglumine Market Overview
1.1 Product Overview and Scope of Gadoterate Meglumine
1.2 Gadoterate Meglumine Segment by Type
1.2.1 Global Gadoterate Meglumine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 1.8845Gm/5Ml
1.2.3 3.769Gm/10Ml
1.2.4 5.6535Gm/15Ml
1.2.5 Others
1.3 Gadoterate Meglumine Segment by Application
1.3.1 Global Gadoterate Meglumine Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Gadoterate Meglumine Market Size Estimates and Forecasts
1.4.1 Global Gadoterate Meglumine Revenue 2016-2027
1.4.2 Global Gadoterate Meglumine Sales 2016-2027
1.4.3 Gadoterate Meglumine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Gadoterate Meglumine Market Competition by Manufacturers
2.1 Global Gadoterate Meglumine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Gadoterate Meglumine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Gadoterate Meglumine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Gadoterate Meglumine Manufacturing Sites, Area Served, Product Type
2.5 Gadoterate Meglumine Market Competitive Situation and Trends
2.5.1 Gadoterate Meglumine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Gadoterate Meglumine Players Market Share by Revenue
2.5.3 Global Gadoterate Meglumine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gadoterate Meglumine Retrospective Market Scenario by Region
3.1 Global Gadoterate Meglumine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Gadoterate Meglumine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Gadoterate Meglumine Market Facts & Figures by Country
3.3.1 North America Gadoterate Meglumine Sales by Country
3.3.2 North America Gadoterate Meglumine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Gadoterate Meglumine Market Facts & Figures by Country
3.4.1 Europe Gadoterate Meglumine Sales by Country
3.4.2 Europe Gadoterate Meglumine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Gadoterate Meglumine Market Facts & Figures by Region
3.5.1 Asia Pacific Gadoterate Meglumine Sales by Region
3.5.2 Asia Pacific Gadoterate Meglumine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Gadoterate Meglumine Market Facts & Figures by Country
3.6.1 Latin America Gadoterate Meglumine Sales by Country
3.6.2 Latin America Gadoterate Meglumine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Gadoterate Meglumine Market Facts & Figures by Country
3.7.1 Middle East and Africa Gadoterate Meglumine Sales by Country
3.7.2 Middle East and Africa Gadoterate Meglumine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Gadoterate Meglumine Historic Market Analysis by Type
4.1 Global Gadoterate Meglumine Sales Market Share by Type (2016-2021)
4.2 Global Gadoterate Meglumine Revenue Market Share by Type (2016-2021)
4.3 Global Gadoterate Meglumine Price by Type (2016-2021)

5 Global Gadoterate Meglumine Historic Market Analysis by Application
5.1 Global Gadoterate Meglumine Sales Market Share by Application (2016-2021)
5.2 Global Gadoterate Meglumine Revenue Market Share by Application (2016-2021)
5.3 Global Gadoterate Meglumine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Guerbet Group
6.1.1 Guerbet Group Corporation Information
6.1.2 Guerbet Group Description and Business Overview
6.1.3 Guerbet Group Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Guerbet Group Gadoterate Meglumine Product Portfolio
6.1.5 Guerbet Group Recent Developments/Updates
6.2 GE
6.2.1 GE Corporation Information
6.2.2 GE Description and Business Overview
6.2.3 GE Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GE Gadoterate Meglumine Product Portfolio
6.2.5 GE Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bayer Gadoterate Meglumine Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Sanochemia
6.4.1 Sanochemia Corporation Information
6.4.2 Sanochemia Description and Business Overview
6.4.3 Sanochemia Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanochemia Gadoterate Meglumine Product Portfolio
6.4.5 Sanochemia Recent Developments/Updates
6.5 T2Pharma
6.5.1 T2Pharma Corporation Information
6.5.2 T2Pharma Description and Business Overview
6.5.3 T2Pharma Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 T2Pharma Gadoterate Meglumine Product Portfolio
6.5.5 T2Pharma Recent Developments/Updates
6.6 b.e.imaging GmbH
6.6.1 b.e.imaging GmbH Corporation Information
6.6.2 b.e.imaging GmbH Description and Business Overview
6.6.3 b.e.imaging GmbH Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 b.e.imaging GmbH Gadoterate Meglumine Product Portfolio
6.6.5 b.e.imaging GmbH Recent Developments/Updates
6.7 Hengrui Medicine
6.6.1 Hengrui Medicine Corporation Information
6.6.2 Hengrui Medicine Description and Business Overview
6.6.3 Hengrui Medicine Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hengrui Medicine Gadoterate Meglumine Product Portfolio
6.7.5 Hengrui Medicine Recent Developments/Updates

7 Gadoterate Meglumine Manufacturing Cost Analysis
7.1 Gadoterate Meglumine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Gadoterate Meglumine
7.4 Gadoterate Meglumine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Gadoterate Meglumine Distributors List
8.3 Gadoterate Meglumine Customers

9 Gadoterate Meglumine Market Dynamics
9.1 Gadoterate Meglumine Industry Trends
9.2 Gadoterate Meglumine Growth Drivers
9.3 Gadoterate Meglumine Market Challenges
9.4 Gadoterate Meglumine Market Restraints

10 Global Market Forecast
10.1 Gadoterate Meglumine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Gadoterate Meglumine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Gadoterate Meglumine by Type (2022-2027)
10.2 Gadoterate Meglumine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Gadoterate Meglumine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Gadoterate Meglumine by Application (2022-2027)
10.3 Gadoterate Meglumine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Gadoterate Meglumine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Gadoterate Meglumine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Gadoterate Meglumine Sales (K L) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Gadoterate Meglumine Sales (K L) Comparison by Application (2021-2027)
Table 3. Global Gadoterate Meglumine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Gadoterate Meglumine Covered in This Study
Table 5. Global Gadoterate Meglumine Sales (K L) of Key Manufacturers (2016-2021)
Table 6. Global Gadoterate Meglumine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Gadoterate Meglumine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Gadoterate Meglumine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Gadoterate Meglumine Average Price (US$/L) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Gadoterate Meglumine Manufacturing Sites and Area Served
Table 11. Manufacturers Gadoterate Meglumine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Gadoterate Meglumine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gadoterate Meglumine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Gadoterate Meglumine Sales by Region (2016-2021) & (K L)
Table 16. Global Gadoterate Meglumine Sales Market Share by Region (2016-2021)
Table 17. Global Gadoterate Meglumine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Gadoterate Meglumine Sales by Country (2016-2021) & (K L)
Table 19. North America Gadoterate Meglumine Sales Market Share by Country (2016-2021)
Table 20. North America Gadoterate Meglumine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Gadoterate Meglumine Revenue Market Share by Country (2016-2021)
Table 22. Europe Gadoterate Meglumine Sales by Country (2016-2021) & (K L)
Table 23. Europe Gadoterate Meglumine Sales Market Share by Country (2016-2021)
Table 24. Europe Gadoterate Meglumine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Gadoterate Meglumine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Gadoterate Meglumine Sales by Region (2016-2021) & (K L)
Table 27. Asia Pacific Gadoterate Meglumine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Gadoterate Meglumine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Gadoterate Meglumine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Gadoterate Meglumine Sales by Country (2016-2021) & (K L)
Table 31. Latin America Gadoterate Meglumine Sales Market Share by Country (2016-2021)
Table 32. Latin America Gadoterate Meglumine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Gadoterate Meglumine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Gadoterate Meglumine Sales by Country (2016-2021) & (K L)
Table 35. Middle East and Africa Gadoterate Meglumine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Gadoterate Meglumine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Gadoterate Meglumine Revenue Market Share by Country (2016-2021)
Table 38. Global Gadoterate Meglumine Sales (K L) by Type (2016-2021)
Table 39. Global Gadoterate Meglumine Sales Market Share by Type (2016-2021)
Table 40. Global Gadoterate Meglumine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Gadoterate Meglumine Revenue Share by Type (2016-2021)
Table 42. Global Gadoterate Meglumine Price (US$/L) by Type (2016-2021)
Table 43. Global Gadoterate Meglumine Sales (K L) by Application (2016-2021)
Table 44. Global Gadoterate Meglumine Sales Market Share by Application (2016-2021)
Table 45. Global Gadoterate Meglumine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Gadoterate Meglumine Revenue Share by Application (2016-2021)
Table 47. Global Gadoterate Meglumine Price (US$/L) by Application (2016-2021)
Table 48. Guerbet Group Corporation Information
Table 49. Guerbet Group Description and Business Overview
Table 50. Guerbet Group Gadoterate Meglumine Sales (K L), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 51. Guerbet Group Gadoterate Meglumine Product
Table 52. Guerbet Group Recent Developments/Updates
Table 53. GE Corporation Information
Table 54. GE Description and Business Overview
Table 55. GE Gadoterate Meglumine Sales (K L), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 56. GE Gadoterate Meglumine Product
Table 57. GE Recent Developments/Updates
Table 58. Bayer Corporation Information
Table 59. Bayer Description and Business Overview
Table 60. Bayer Gadoterate Meglumine Sales (K L), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 61. Bayer Gadoterate Meglumine Product
Table 62. Bayer Recent Developments/Updates
Table 63. Sanochemia Corporation Information
Table 64. Sanochemia Description and Business Overview
Table 65. Sanochemia Gadoterate Meglumine Sales (K L), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 66. Sanochemia Gadoterate Meglumine Product
Table 67. Sanochemia Recent Developments/Updates
Table 68. T2Pharma Corporation Information
Table 69. T2Pharma Description and Business Overview
Table 70. T2Pharma Gadoterate Meglumine Sales (K L), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 71. T2Pharma Gadoterate Meglumine Product
Table 72. T2Pharma Recent Developments/Updates
Table 73. b.e.imaging GmbH Corporation Information
Table 74. b.e.imaging GmbH Description and Business Overview
Table 75. b.e.imaging GmbH Gadoterate Meglumine Sales (K L), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 76. b.e.imaging GmbH Gadoterate Meglumine Product
Table 77. b.e.imaging GmbH Recent Developments/Updates
Table 78. Hengrui Medicine Corporation Information
Table 79. Hengrui Medicine Description and Business Overview
Table 80. Hengrui Medicine Gadoterate Meglumine Sales (K L), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 81. Hengrui Medicine Gadoterate Meglumine Product
Table 82. Hengrui Medicine Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Gadoterate Meglumine Distributors List
Table 86. Gadoterate Meglumine Customers List
Table 87. Gadoterate Meglumine Market Trends
Table 88. Gadoterate Meglumine Growth Drivers
Table 89. Gadoterate Meglumine Market Challenges
Table 90. Gadoterate Meglumine Market Restraints
Table 91. Global Gadoterate Meglumine Sales Forecast by Type (2022-2027) & (K L)
Table 92. Global Gadoterate Meglumine Sales Market Share Forecast by Type (2022-2027)
Table 93. Global Gadoterate Meglumine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 94. Global Gadoterate Meglumine Revenue Market Share Forecast by Type (2022-2027)
Table 95. Global Gadoterate Meglumine Sales Forecast by Application (2022-2027) & (K L)
Table 96. Global Gadoterate Meglumine Sales Market Share Forecast by Application (2022-2027)
Table 97. Global Gadoterate Meglumine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 98. Global Gadoterate Meglumine Revenue Market Share Forecast by Application (2022-2027)
Table 99. Global Gadoterate Meglumine Sales Forecast by Region (2022-2027) & (K L)
Table 100. Global Gadoterate Meglumine Sales Market Share Forecast by Region (2022-2027)
Table 101. Global Gadoterate Meglumine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 102. Global Gadoterate Meglumine Revenue Market Share Forecast by Region (2022-2027)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gadoterate Meglumine
Figure 2. Global Gadoterate Meglumine Market Share by Type in 2020 & 2027
Figure 3. 1.8845Gm/5Ml Product Picture
Figure 4. 3.769Gm/10Ml Product Picture
Figure 5. 5.6535Gm/15Ml Product Picture
Figure 6. Others Product Picture
Figure 7. Global Gadoterate Meglumine Market Share by Application in 2020 & 2027
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Global Gadoterate Meglumine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Gadoterate Meglumine Market Size 2016-2027 (US$ Million)
Figure 12. Global Gadoterate Meglumine Sales 2016-2027 (K L)
Figure 13. Global Gadoterate Meglumine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Gadoterate Meglumine Sales Share by Manufacturers in 2020
Figure 15. Global Gadoterate Meglumine Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Gadoterate Meglumine Players: Market Share by Revenue in 2020
Figure 17. Gadoterate Meglumine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Gadoterate Meglumine Sales Market Share by Region (2016-2021)
Figure 19. Global Gadoterate Meglumine Sales Market Share by Region in 2020
Figure 20. Global Gadoterate Meglumine Revenue Market Share by Region (2016-2021)
Figure 21. Global Gadoterate Meglumine Revenue Market Share by Region in 2020
Figure 22. United States Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Taiwan Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Gadoterate Meglumine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Gadoterate Meglumine by Type (2016-2021)
Figure 45. Sales Market Share of Gadoterate Meglumine by Application (2016-2021)
Figure 46. Sales Market Share of Gadoterate Meglumine by Application in 2020
Figure 47. Revenue Share of Gadoterate Meglumine by Application (2016-2021)
Figure 48. Revenue Share of Gadoterate Meglumine by Application in 2020
Figure 49. Manufacturing Cost Structure of Gadoterate Meglumine
Figure 50. Manufacturing Process Analysis of Gadoterate Meglumine
Figure 51. Gadoterate Meglumine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed